SEC Form 4 · accession 0001437749-18-012166
BIOLIFE SOLUTIONS INC · BLFS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Rice
Officer — President & CEO · Director
Period of report
Jun 18, 2018
Accepted (ET)
Jun 20, 2018 · 9:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000834365
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 18, 2018 | M | 12,540 | $1.12 | A | 152,057 | D | |
| Common Stock | Jun 18, 2018 | S | 12,540 | $12.89 | D | 139,517 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option | $1.12 | Jun 18, 2018 | M | 12,540 | D | Aug 14, 2012 | Feb 24, 2021 | Common Stock | 12,540 | 85,327 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017, the terms of which have been disclosed in a Form 8-K filed by BioLife Solutions, Inc. on December 14, 2017.